Position in HCM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,897,835
-$6,205,475 QoQ
Shares Held
1,477,494
0.0% QoQ
Ownership
0.850%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 56 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HCM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $225,719,959 across 11 Drug Manufacturers - Specialty & Generic names. HCM ranks #6 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,280,484 | $77,262,797 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
72,306 | $39,177,559 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
1,129,781 | $39,169,506 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
1,618,404 | $23,450,672 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
368,017 | $17,116,470 | |
| 6 | HCM |
HUTCHMED (China) Ltd
This page
|
1,477,494 | $15,897,835 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
333,656 | $8,211,273 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
16,253 | $2,739,280 |
All Filings in HCM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,897,835 | 1,477,494 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $22,103,310 | 1,477,494 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $30,386,281 | 2,279,541 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $38,857,281 | 2,467,129 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $38,819,201 | 2,579,349 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $42,766,434 | 2,843,513 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $39,900,439 | 2,768,941 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $57,099,216 | 2,923,667 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $51,776,648 | 3,024,337 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $64,676,522 | 3,849,793 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $75,696,829 | 4,179,836 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $71,472,705 | 4,219,168 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $55,232,052 | 4,602,671 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $59,480,098 | 4,568,364 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $68,827,267 | 4,656,784 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $38,455,906 | 4,340,396 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $44,045,583 | 3,484,619 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $64,519,601 | 3,410,127 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $106,285,645 | 3,102,043 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $63,024,214 | 3,030,051 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $43,186,748 | 1,099,739 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $113,443,184 | 4,015,688 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $125,391,759 | 3,916,045 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $123,103,502 | 3,811,254 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $111,654,649 | 4,048,392 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $71,112,792 | 3,983,910 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||